The latest from across eye care — curated by B-Seen
Exogenous endophthalmitis is a devastating complication of any intraocular procedure that can occur despite the most stringent antiseptic techniques. Fortunately, the rates of endophthalmitis after intraocular procedures are low and have declined steadily over the last 20 years.1 Unfortunately, visual outcomes are highly variable and often additional complications develop, including retinal detachments, macular edema, and hypotony, among others.2 Clinical decision-making in endophthalmitis cases has been guided largely by the Endophthalmitis Vitrectomy Study (EVS) published in 1995.
JENA, Germany—Bronwyn Brophy O'Connor has been named the new CEO of Carl Zeiss Meditec AG, Zeiss Group has announced. She has also been named as the new executive board member of Carl Zeiss AG responsible for the Medical Technology segment. In this role, O’Connor, who presently serves as CEO of the NASDAQ Stockholm-listed Vitrolife Group (VITR.ST), a global med-tech company in Sweden, will succeed Andreas Pecher, who, in addition to his primary role as president and CEO of Carl Zeiss AG, has served as CEO of Carl Zeiss Meditec AG on an interim basis since January 1, 2026.
HELSINKI — A study showed that the functional response of corneal allogenic intrastromal ring segments is influenced by keratoconus morphology. It also demonstrated that the segments provide meaningful structural and functional improvements. At the European Society of Cataract and Refractive Surgeons winter meeting, Burcu Yakut, MD, said that the findings offer “guidance for patient selection and surgical planning.” The study, conducted by Aylin Klç, MD, and colleagues, compared visual, refractive and tomographic outcomes of corneal allogenic intrastromal ring segments (CAIRS) in patients with
LEXINGTON, Ky.—The National Academy of Opticianry (NAO) and the United Opticians Association (UOA) announced that the NAO fellow members, and the UOA board of directors, each voted to authorize the beginning of the formal merger or asset-transfer process between the two organizations. These actions follow the letter of intent jointly approved by both boards in April and represent a coordinated commitment to advance the next phase of due diligence and planning, according to the announcement.
LAT KRABANG, Thailand—EssilorLuxottica (Euronext Paris: EL) has reached what it has identified as an important milestone in its innovation journey with the opening of a new research and development (R&D) center in Lat Krabang, Thailand, designed to accelerate how it develops, scales, and delivers the next generation of vision care solutions, wearables and medical technologies. Located near its major manufacturing facilities, the 5,000-square-meter center will serve as a strategic hub for ophthalmic lens materials and manufacturing technologies, the company advised, bringing together the entire value chain, from advanced materials research to industrial process development.
ST. LOUIS—On Wednesday, the American Optometric Association (AOA) announced that it is asking the Federal Trade Commission (FTC) to look into what it said are possible Eyeglass Rule infractions by Eyebot, developer of automated vision testing technology, and 1-800 Contacts, with which Eyebot announced a partnership earlier this year. AOA concerns stem from what it said is an automated kiosk in a Utah mall with 1-800-Contacts branding featuring marketing language that offers “free glasses prescriptions.” This language, the AOA said, “raises significant concerns regarding compliance” with the Eyeglass Rule, known officially as Ophthalmic Practice Rules, which establish a set of requirements around providing ophthalmology and optometry patients with a free copy of their prescription immediately following a refractive eye exam.
A 65-year-old woman presented with an amelanotic mass in the anterior chamber of the right eye, 25 years after penetrating trauma. Visual acuity was light perception in the right eye. Slit-lamp examination showed an inferonasal corneal scar and a lobulated pearly-white lesion arising from the nasal aspect (A). Anterior-segment OCT revealed a cystic lesion with a hyperreflective anterior wall touching the corneal endothelium, plus a healed corneal laceration (B, ∗) and a fistulous tract connecting to the cyst (C, arrow), embedded in the stroma.
In FECD, progression to keratoplasty is unpredictable. We show that genomic risk profiling, including CTG18.1 expansion status and a disease-specific polygenic risk score, predicts keratoplasty risk with findings validated across independent cohorts.
The currently available body of evidence is not strong enough to support vitamin supplementation as a treatment for dry eye disease, with particular gaps around vitamins C and B12, according to a review. “Many patients [with dry eye disease] continue to experience persistent symptoms despite conventional therapies,” study author Hamidreza Heidari, MSc Optom, FBCLA, a PhD candidate at UNSW Sydney, told Healio. “There has been growing interest in the role of nutrition in addressing ocular surface diseases. ... However, the available evidence was scattered and inconsistent.”
Global markets, networking and creative cross-contamination are at the core of the vision of Davide Degl’Incerti Tocci, the ANFAO vice president responsible for the Young Entrepreneurs Group, Digitalization, Internationalization and president of DaTE.
A 90-year-old white woman with a medical history of coronary artery disease, congestive heart failure and hypertension presented to her local eye doctor for a routine eye exam. The patient also had a history of hyperlipidemia and multiple cutaneous squamous cell carcinoma lesions (status post Mohs excision). Her chief concern was new drooping of her right upper eyelid. She said the drooping had been happening for about 6 months, with intermittent headaches and increased tearing from her right eye. Her headaches improved with Tylenol (acetaminophen, Kenvue). She denied any other visual or ocular
Cataract surgeons need to be aware of pseudoexfoliation syndrome, a systemic basement membrane disorder that compromises the structural integrity of the lens suspension system, pupil dilation and aqueous outflow pathways. For the experienced surgeon, success is found in anticipating zonular failure before it becomes an intraoperative crisis. By focusing on a few critical pearls identified during the key stages of the procedure, a surgeon can navigate these high-risk cases with the same predictability as a routine operation. Success in a pseudoexfoliation case begins at the slit lamp microscope
FOND-DES-BLANCS, Haiti—What began as short clinical missions and two-week volunteer trips for Anshu Chandra, OD, has grown into the Global Eye Project (GEP), a nonprofit delivering comprehensive eyecare to one of Haiti’s most isolated regions and training for the next generation of local eyecare providers. Launched in 2015, GEP’s clinic in the rural commune of Fond des Blancs in Haiti has now provided more than 132,000 free eye exams to date and reaches up to 15,000 patients annually. But that work didn’t happen overnight.
COLUMBIA, Md.—Foundation Fighting Blindness celebrates Jean Bennett, MD, who recently won the prestigious 2026 Breakthrough Prize in Life Sciences, awarded to the Children's Hospital of Philadelphia and Penn Medicine team for developing the first FDA-approved gene therapy for an inherited retinal disease. Dr. Bennett, along with her husband, Albert Maguire, MD, and collaborator Katherine High, MD, received this $3 million award for their groundbreaking work that led to Luxturna (voretigene neparvovec-rzyl), the gene therapy that treats RPE65 mutation-associated retinal diseases, according to an announcement from Foundation Fighting Blindness.
NEW YORK—Sunglass Hut has launched the next chapter of its “Own Your Moment” campaign, which stars an international lineup of talent across sport, music and entertainment. The campaign is designed to “celebrate the transformative power of sunglasses,” the company said, positioning sunglasses as a statement of self-expression. The campaign will star basketball icon Breanna Stewart in the U.S., pop legend Melanie C in the U.K., and Spanish actress María Pedraza in Spain, with each ambassador bringing their own perspective on style and individuality, according to an announcement from Sunglass Hut.
Doctors who have not yet started using AI tools should first get comfortable using them in everyday life before adopting them in clinical practice. That is the advice from optometrist Scott A. Edmonds, OD, FAAO, a member of the Healio AI Advisory Board who has been using AI in various areas of his practice. “You learn to use the tool in a much less stressful environment,” Edmonds said. “You learn how the model works and how it thinks. ... Then when I go to use it in the real world, in the clinic, I’m more attuned. I’m not afraid of it. I know what to ask it. “Play with it in everyday life first,
MIAMI — In this video from Sunshine Eye & Retina, Neel R. Desai, MD, discusses the benefits of decellularized basement membrane. Desai said Biovance 3L (DefEYE) amniotic membrane offers fast healing while allowing for shorter procedure times and positive outcomes for patients. {{VIDEO}} “I think this deserves its own unique category because of its tissue processing,” Desai told Healio. “Decellularized membrane uniquely is just the bioactive basement membrane of the amnion. It is triple layered in Biovance 3L, so we have this purified scaffold for healing and wound coverage that provides for
Doyle Optometrists and Opticians marks its entry into the Outaouais region with the recent opening of its 27th location in the Aylmer sector. This opening is part of the company’s continued, sustained growth. Two well-established local professionals are joining the project as co-owners: Dr. Janie Boucher, optometrist, and Édith Métayer, dispensing optician.
KANSAS CITY, Mo.—In April, the PERC and Opti-Port alliances hosted the 2026 Spring Elevate Conference in Kansas City, bringing together a group of independent eyecare leaders for a business-focused event that centered on growth, performance and leadership. This year, Elevate was themed “Here to Win,” underscoring a commitment to continuous improvement and growth, according to an announcement from the alliances. As reported in VMAIL, Elevate attracts practice owners who are both succeeding in today’s market and actively working to outperform it, the announcement noted.
WEST VALLEY CITY, Utah—Premier Vision Lab, a full-service optical laboratory based in Salt Lake City, has announced its transition from a doctor-owned model to fully independent ownership. With this change, Premier Vision Lab is opening its doors to eyecare practices across the region, as reported in VMAIL. This acquisition was completed in December 2025 by Afshin Baghai and Ben Rollins. Baghai founded the lab in 2007 alongside a group of local optometrists and has served as lab director ever since. His tenure spans the full arc of the lab's growth and represents a level of institutional knowledge rare in the independent lab space, the announcement said. Rollins is the founder of Axon Optics with a background in optical technology and vision care, including work with technologies developed at the Moran Eye Center at the University of Utah.
ROCHESTER, N.Y.—CooperVision announced it has completed enrollment of its global MiSight 1 day post-approval clinical studies (PAS) in the U.S. and China, described by the company as a milestone in real-world evidence generation for pediatric myopia control. Together, these studies represent the longest international clinical evidence program ever undertaken for soft contact lens-based myopia control intervention in children, according to the company, including both randomized controlled efficacy trials and large-scale safety registries. The combined PAS programs span more than 100 clinical sites and include over 3,000 children.
MOUNTAIN VIEW, Calif.—During Google I/O 2026 held this week, Google revealed the latest updates as it drives toward the release of intelligent eyewear before the year is out. Shared via the company’s corporate blog, the announcement indicates that Google will be releasing two types of intelligent eyewear, including both audio and display glasses, with the former configuration scheduled for release first, debuting later this fall. The news marks the latest milestone following the company’s announcement one year ago that it would be partnering with three major eyewear companies—Warby Parker Inc., (NYSE: WRBY) Kering Eyewear and Gentle Monster—for the development of smart glasses grounded in its Android XR platform.
MEMPHIS, Tenn.—Southern College of Optometry (SCO) has elected alumna Belinda Starkey, OD, and William McDonald to its board of trustees, the school announced. Both bring an abundance of knowledge in organizational management and oversight to the college, ensuring it remains a top educational institution for current and future students, as well as community members receiving care at its associated clinics, the announcement noted. Dr. Starkey and McDonald join 13 other trustees who oversee the management of SCO.
NEW YORK—Orbis International, a global eyecare nonprofit, and Siloam Vision, a company focused on bringing technology to market to reduce preventable blindness worldwide, recently announced the launch of an AI-assisted retinopathy of prematurity (ROP) screening program at the the National Center for Maternal and Child Health (NCMCH) neonatal intensive care unit in Ulaanbaatar, Mongolia, an Orbis partner hospital. Launched in 2023, the partnership between Orbis and Siloam Vision, combines Siloam’s proprietary AI technology with Orbis’s health systems-strengthening model and long-term partnerships in local communities to extend high-quality eyecare to premature infants in some of the world’s hardest-to-reach areas, the announcement noted.
Studies show that GLP-1 receptor agonists have significant potential for treating glaucoma, diabetic retinopathy and other eye diseases, but important nuances remain to be investigated, according to a review published in BMC Ophthalmology. “Although GLP-1 RAs have revolutionized metabolic disease management, their potential therapeutic role in ocular diseases — particularly those driven by shared metabolic and inflammatory pathways — remains underexplored,” Yu Luo, of Beijing University of Chinese Medicine, and colleagues wrote. “Their multifaceted neuroprotective
FORT LAUDERDALE, Fla. — Dopamine signaling may play a role in age-related macular degeneration, as shown through a possible association between dopamine antagonists and disease progression, according to a presenter. “Dopamine is not just a neurotransmitter in the brain; it is also produced in the retina, and it plays important roles in light adaptation, cellular signaling and vascular regulation,” Sharon Fekrat, MD, FASRS, a retina specialist at Duke Health, told Healio at Retina World Congress. “Building on experimental evidence suggesting dopamine may inhibit abnormal angiogenesis, we
FYidoctors is marking a notable year of corporate recognition, having achieved Platinum Club status as one of Canada’s Best Managed Companies while also being named among Canada’s Best Workplaces, in addition to earning distinctions as a Best Workplace for Women and for having one of the Most Trusted Executive Teams.
What do you see in your mind’s eye when you write that first prescription for your new symptomatic patient with dry eye disease? Me? I look up above the slit lamp and see a 50-foot wall with hundreds of medieval archers ready to rain destruction on us if I sign that script. Not to mention the multitude of horrors that await us in the prior authorization dungeons should we make it past the castle gates. Wait! Is that a real, live gargoyle about to pour boiling oil on us? If this is what I, a highly experienced, adequately cynical dry eye expert, see, imagine what it feels like if you are that
What do you see in your mind’s eye when you write that first prescription for your new symptomatic patient with dry eye disease? Me? I look up above the slit lamp and see a 50-foot wall with hundreds of medieval archers ready to rain destruction on us if I sign that script. Not to mention the multitude of horrors that await us in the prior authorization dungeons should we make it past the castle gates. Wait! Is that a real, live gargoyle about to pour boiling oil on us? If this is what I, a highly experienced, adequately cynical dry eye expert, see, imagine what it feels like if you are that
NEW YORK—Warby Parker Inc. (NYSE: WRBY), a direct-to-consumer lifestyle brand, unveiled its first Intelligent Eyewear frame designed for all-day, everyday wear on Tuesday, May 19, at Google I/O 2026, according to an announcement from the company. Built in partnership with Google and Samsung, the frames feature Gemini and work with Android XR to provide contextual, real-time assistance. Wearers will be able to access information, manage daily tasks, navigate their surroundings, communicate seamlessly, and interact with the apps they already use every day. The company said it plans to launch its first line of Intelligent Eyewear later this fall.
MONTREAL—WestGroupe has announced the retirement of Beverly Suliteanu, vice president, product development and creative director, effective May 31, 2026. In making the announcement, the company said Suliteanu’s retirement “marks the close of an extraordinary chapter in the company’s history and the evolution of a family-led business.” A second-generation leader, Suliteanu has been an integral part of WestGroupe’s leadership for more than three decades, working alongside her brother, Michael Suliteanu, and Mike DeBono. As part of this transition, WestGroupe has announced the appointment of Natalie Lacroce as vice president, brand and product planning.
Exogenous endophthalmitis is a devastating complication of any intraocular procedure that can occur despite the most stringent antiseptic techniques. Fortunately, the rates of endophthalmitis after intraocular procedures are low and have declined steadily over the last 20 years.1 Unfortunately, visual outcomes are highly variable and often additional complications develop, including retinal detachments, macular edema, and hypotony, among others.2 Clinical decision-making in endophthalmitis cases has been guided largely by the Endophthalmitis Vitrectomy Study (EVS) published in 1995.
JENA, Germany—Bronwyn Brophy O'Connor has been named the new CEO of Carl Zeiss Meditec AG, Zeiss Group has announced. She has also been named as the new executive board member of Carl Zeiss AG responsible for the Medical Technology segment. In this role, O’Connor, who presently serves as CEO of the NASDAQ Stockholm-listed Vitrolife Group (VITR.ST), a global med-tech company in Sweden, will succeed Andreas Pecher, who, in addition to his primary role as president and CEO of Carl Zeiss AG, has served as CEO of Carl Zeiss Meditec AG on an interim basis since January 1, 2026.
HELSINKI — A study showed that the functional response of corneal allogenic intrastromal ring segments is influenced by keratoconus morphology. It also demonstrated that the segments provide meaningful structural and functional improvements. At the European Society of Cataract and Refractive Surgeons winter meeting, Burcu Yakut, MD, said that the findings offer “guidance for patient selection and surgical planning.” The study, conducted by Aylin Klç, MD, and colleagues, compared visual, refractive and tomographic outcomes of corneal allogenic intrastromal ring segments (CAIRS) in patients with
LEXINGTON, Ky.—The National Academy of Opticianry (NAO) and the United Opticians Association (UOA) announced that the NAO fellow members, and the UOA board of directors, each voted to authorize the beginning of the formal merger or asset-transfer process between the two organizations. These actions follow the letter of intent jointly approved by both boards in April and represent a coordinated commitment to advance the next phase of due diligence and planning, according to the announcement.
LAT KRABANG, Thailand—EssilorLuxottica (Euronext Paris: EL) has reached what it has identified as an important milestone in its innovation journey with the opening of a new research and development (R&D) center in Lat Krabang, Thailand, designed to accelerate how it develops, scales, and delivers the next generation of vision care solutions, wearables and medical technologies. Located near its major manufacturing facilities, the 5,000-square-meter center will serve as a strategic hub for ophthalmic lens materials and manufacturing technologies, the company advised, bringing together the entire value chain, from advanced materials research to industrial process development.
ST. LOUIS—On Wednesday, the American Optometric Association (AOA) announced that it is asking the Federal Trade Commission (FTC) to look into what it said are possible Eyeglass Rule infractions by Eyebot, developer of automated vision testing technology, and 1-800 Contacts, with which Eyebot announced a partnership earlier this year. AOA concerns stem from what it said is an automated kiosk in a Utah mall with 1-800-Contacts branding featuring marketing language that offers “free glasses prescriptions.” This language, the AOA said, “raises significant concerns regarding compliance” with the Eyeglass Rule, known officially as Ophthalmic Practice Rules, which establish a set of requirements around providing ophthalmology and optometry patients with a free copy of their prescription immediately following a refractive eye exam.
A 65-year-old woman presented with an amelanotic mass in the anterior chamber of the right eye, 25 years after penetrating trauma. Visual acuity was light perception in the right eye. Slit-lamp examination showed an inferonasal corneal scar and a lobulated pearly-white lesion arising from the nasal aspect (A). Anterior-segment OCT revealed a cystic lesion with a hyperreflective anterior wall touching the corneal endothelium, plus a healed corneal laceration (B, ∗) and a fistulous tract connecting to the cyst (C, arrow), embedded in the stroma.
In FECD, progression to keratoplasty is unpredictable. We show that genomic risk profiling, including CTG18.1 expansion status and a disease-specific polygenic risk score, predicts keratoplasty risk with findings validated across independent cohorts.
The currently available body of evidence is not strong enough to support vitamin supplementation as a treatment for dry eye disease, with particular gaps around vitamins C and B12, according to a review. “Many patients [with dry eye disease] continue to experience persistent symptoms despite conventional therapies,” study author Hamidreza Heidari, MSc Optom, FBCLA, a PhD candidate at UNSW Sydney, told Healio. “There has been growing interest in the role of nutrition in addressing ocular surface diseases. ... However, the available evidence was scattered and inconsistent.”
Global markets, networking and creative cross-contamination are at the core of the vision of Davide Degl’Incerti Tocci, the ANFAO vice president responsible for the Young Entrepreneurs Group, Digitalization, Internationalization and president of DaTE.
A 90-year-old white woman with a medical history of coronary artery disease, congestive heart failure and hypertension presented to her local eye doctor for a routine eye exam. The patient also had a history of hyperlipidemia and multiple cutaneous squamous cell carcinoma lesions (status post Mohs excision). Her chief concern was new drooping of her right upper eyelid. She said the drooping had been happening for about 6 months, with intermittent headaches and increased tearing from her right eye. Her headaches improved with Tylenol (acetaminophen, Kenvue). She denied any other visual or ocular
Cataract surgeons need to be aware of pseudoexfoliation syndrome, a systemic basement membrane disorder that compromises the structural integrity of the lens suspension system, pupil dilation and aqueous outflow pathways. For the experienced surgeon, success is found in anticipating zonular failure before it becomes an intraoperative crisis. By focusing on a few critical pearls identified during the key stages of the procedure, a surgeon can navigate these high-risk cases with the same predictability as a routine operation. Success in a pseudoexfoliation case begins at the slit lamp microscope
FOND-DES-BLANCS, Haiti—What began as short clinical missions and two-week volunteer trips for Anshu Chandra, OD, has grown into the Global Eye Project (GEP), a nonprofit delivering comprehensive eyecare to one of Haiti’s most isolated regions and training for the next generation of local eyecare providers. Launched in 2015, GEP’s clinic in the rural commune of Fond des Blancs in Haiti has now provided more than 132,000 free eye exams to date and reaches up to 15,000 patients annually. But that work didn’t happen overnight.
COLUMBIA, Md.—Foundation Fighting Blindness celebrates Jean Bennett, MD, who recently won the prestigious 2026 Breakthrough Prize in Life Sciences, awarded to the Children's Hospital of Philadelphia and Penn Medicine team for developing the first FDA-approved gene therapy for an inherited retinal disease. Dr. Bennett, along with her husband, Albert Maguire, MD, and collaborator Katherine High, MD, received this $3 million award for their groundbreaking work that led to Luxturna (voretigene neparvovec-rzyl), the gene therapy that treats RPE65 mutation-associated retinal diseases, according to an announcement from Foundation Fighting Blindness.
NEW YORK—Sunglass Hut has launched the next chapter of its “Own Your Moment” campaign, which stars an international lineup of talent across sport, music and entertainment. The campaign is designed to “celebrate the transformative power of sunglasses,” the company said, positioning sunglasses as a statement of self-expression. The campaign will star basketball icon Breanna Stewart in the U.S., pop legend Melanie C in the U.K., and Spanish actress María Pedraza in Spain, with each ambassador bringing their own perspective on style and individuality, according to an announcement from Sunglass Hut.
Doctors who have not yet started using AI tools should first get comfortable using them in everyday life before adopting them in clinical practice. That is the advice from optometrist Scott A. Edmonds, OD, FAAO, a member of the Healio AI Advisory Board who has been using AI in various areas of his practice. “You learn to use the tool in a much less stressful environment,” Edmonds said. “You learn how the model works and how it thinks. ... Then when I go to use it in the real world, in the clinic, I’m more attuned. I’m not afraid of it. I know what to ask it. “Play with it in everyday life first,
MIAMI — In this video from Sunshine Eye & Retina, Neel R. Desai, MD, discusses the benefits of decellularized basement membrane. Desai said Biovance 3L (DefEYE) amniotic membrane offers fast healing while allowing for shorter procedure times and positive outcomes for patients. {{VIDEO}} “I think this deserves its own unique category because of its tissue processing,” Desai told Healio. “Decellularized membrane uniquely is just the bioactive basement membrane of the amnion. It is triple layered in Biovance 3L, so we have this purified scaffold for healing and wound coverage that provides for
Doyle Optometrists and Opticians marks its entry into the Outaouais region with the recent opening of its 27th location in the Aylmer sector. This opening is part of the company’s continued, sustained growth. Two well-established local professionals are joining the project as co-owners: Dr. Janie Boucher, optometrist, and Édith Métayer, dispensing optician.
KANSAS CITY, Mo.—In April, the PERC and Opti-Port alliances hosted the 2026 Spring Elevate Conference in Kansas City, bringing together a group of independent eyecare leaders for a business-focused event that centered on growth, performance and leadership. This year, Elevate was themed “Here to Win,” underscoring a commitment to continuous improvement and growth, according to an announcement from the alliances. As reported in VMAIL, Elevate attracts practice owners who are both succeeding in today’s market and actively working to outperform it, the announcement noted.
WEST VALLEY CITY, Utah—Premier Vision Lab, a full-service optical laboratory based in Salt Lake City, has announced its transition from a doctor-owned model to fully independent ownership. With this change, Premier Vision Lab is opening its doors to eyecare practices across the region, as reported in VMAIL. This acquisition was completed in December 2025 by Afshin Baghai and Ben Rollins. Baghai founded the lab in 2007 alongside a group of local optometrists and has served as lab director ever since. His tenure spans the full arc of the lab's growth and represents a level of institutional knowledge rare in the independent lab space, the announcement said. Rollins is the founder of Axon Optics with a background in optical technology and vision care, including work with technologies developed at the Moran Eye Center at the University of Utah.
ROCHESTER, N.Y.—CooperVision announced it has completed enrollment of its global MiSight 1 day post-approval clinical studies (PAS) in the U.S. and China, described by the company as a milestone in real-world evidence generation for pediatric myopia control. Together, these studies represent the longest international clinical evidence program ever undertaken for soft contact lens-based myopia control intervention in children, according to the company, including both randomized controlled efficacy trials and large-scale safety registries. The combined PAS programs span more than 100 clinical sites and include over 3,000 children.
MOUNTAIN VIEW, Calif.—During Google I/O 2026 held this week, Google revealed the latest updates as it drives toward the release of intelligent eyewear before the year is out. Shared via the company’s corporate blog, the announcement indicates that Google will be releasing two types of intelligent eyewear, including both audio and display glasses, with the former configuration scheduled for release first, debuting later this fall. The news marks the latest milestone following the company’s announcement one year ago that it would be partnering with three major eyewear companies—Warby Parker Inc., (NYSE: WRBY) Kering Eyewear and Gentle Monster—for the development of smart glasses grounded in its Android XR platform.
MEMPHIS, Tenn.—Southern College of Optometry (SCO) has elected alumna Belinda Starkey, OD, and William McDonald to its board of trustees, the school announced. Both bring an abundance of knowledge in organizational management and oversight to the college, ensuring it remains a top educational institution for current and future students, as well as community members receiving care at its associated clinics, the announcement noted. Dr. Starkey and McDonald join 13 other trustees who oversee the management of SCO.
NEW YORK—Orbis International, a global eyecare nonprofit, and Siloam Vision, a company focused on bringing technology to market to reduce preventable blindness worldwide, recently announced the launch of an AI-assisted retinopathy of prematurity (ROP) screening program at the the National Center for Maternal and Child Health (NCMCH) neonatal intensive care unit in Ulaanbaatar, Mongolia, an Orbis partner hospital. Launched in 2023, the partnership between Orbis and Siloam Vision, combines Siloam’s proprietary AI technology with Orbis’s health systems-strengthening model and long-term partnerships in local communities to extend high-quality eyecare to premature infants in some of the world’s hardest-to-reach areas, the announcement noted.
Studies show that GLP-1 receptor agonists have significant potential for treating glaucoma, diabetic retinopathy and other eye diseases, but important nuances remain to be investigated, according to a review published in BMC Ophthalmology. “Although GLP-1 RAs have revolutionized metabolic disease management, their potential therapeutic role in ocular diseases — particularly those driven by shared metabolic and inflammatory pathways — remains underexplored,” Yu Luo, of Beijing University of Chinese Medicine, and colleagues wrote. “Their multifaceted neuroprotective
FORT LAUDERDALE, Fla. — Dopamine signaling may play a role in age-related macular degeneration, as shown through a possible association between dopamine antagonists and disease progression, according to a presenter. “Dopamine is not just a neurotransmitter in the brain; it is also produced in the retina, and it plays important roles in light adaptation, cellular signaling and vascular regulation,” Sharon Fekrat, MD, FASRS, a retina specialist at Duke Health, told Healio at Retina World Congress. “Building on experimental evidence suggesting dopamine may inhibit abnormal angiogenesis, we
FYidoctors is marking a notable year of corporate recognition, having achieved Platinum Club status as one of Canada’s Best Managed Companies while also being named among Canada’s Best Workplaces, in addition to earning distinctions as a Best Workplace for Women and for having one of the Most Trusted Executive Teams.
What do you see in your mind’s eye when you write that first prescription for your new symptomatic patient with dry eye disease? Me? I look up above the slit lamp and see a 50-foot wall with hundreds of medieval archers ready to rain destruction on us if I sign that script. Not to mention the multitude of horrors that await us in the prior authorization dungeons should we make it past the castle gates. Wait! Is that a real, live gargoyle about to pour boiling oil on us? If this is what I, a highly experienced, adequately cynical dry eye expert, see, imagine what it feels like if you are that
What do you see in your mind’s eye when you write that first prescription for your new symptomatic patient with dry eye disease? Me? I look up above the slit lamp and see a 50-foot wall with hundreds of medieval archers ready to rain destruction on us if I sign that script. Not to mention the multitude of horrors that await us in the prior authorization dungeons should we make it past the castle gates. Wait! Is that a real, live gargoyle about to pour boiling oil on us? If this is what I, a highly experienced, adequately cynical dry eye expert, see, imagine what it feels like if you are that
NEW YORK—Warby Parker Inc. (NYSE: WRBY), a direct-to-consumer lifestyle brand, unveiled its first Intelligent Eyewear frame designed for all-day, everyday wear on Tuesday, May 19, at Google I/O 2026, according to an announcement from the company. Built in partnership with Google and Samsung, the frames feature Gemini and work with Android XR to provide contextual, real-time assistance. Wearers will be able to access information, manage daily tasks, navigate their surroundings, communicate seamlessly, and interact with the apps they already use every day. The company said it plans to launch its first line of Intelligent Eyewear later this fall.
MONTREAL—WestGroupe has announced the retirement of Beverly Suliteanu, vice president, product development and creative director, effective May 31, 2026. In making the announcement, the company said Suliteanu’s retirement “marks the close of an extraordinary chapter in the company’s history and the evolution of a family-led business.” A second-generation leader, Suliteanu has been an integral part of WestGroupe’s leadership for more than three decades, working alongside her brother, Michael Suliteanu, and Mike DeBono. As part of this transition, WestGroupe has announced the appointment of Natalie Lacroce as vice president, brand and product planning.
B-Seen aggregates headlines from leading eye care publications. All content belongs to its respective publishers. Want your publication featured or removed? Contact us.
